Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Ambavane%2C+Apoorva%22&type=Person&sort=year
/vufind/Search/Results?lookfor=%22Ambavane%2C+Apoorva%22&type=Person&sort=year
Search /vufind/Search2/Results?lookfor=%22Ambavane%2C+Apoorva%22&type=Person&sort=year
PubPharm (21)
1
Modeling health outcomes associated with BRCA testing and treatment strategies for patients with metastatic pancreatic cancer
enthalten in:
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.
| 2024
von
Agnihotri, N.
|
Ambavane, A.
|
Fan, L.
| +4
Wird geladen...
2
Belantamab mafodotin for the treatment of relapsed/refractory multiple myeloma in heavily pretreated patients : a US cost-effectiveness analysis
enthalten in:
Expert review of hematology
| 2021
von
Nikolaou, A.
|
Ambavane, A.
|
Shah, A.
| +11
Wird geladen...
3
Budget impact of tepotinib in the treatment of adult patients with metastatic non-small cell lung cancer harboring METex14 skipping alterations in the United States
enthalten in:
Journal of medical economics
| 2021
von
Stargardter, M.
|
McBride, A.
|
Tosh, J.
| +6
Wird geladen...
4
Budget Impact of Belantamab Mafodotin (Belamaf) Adoption in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma in the United States
enthalten in:
ClinicoEconomics and outcomes research : CEOR
| 2021
von
Shah, A.
|
Tosh, J.
|
Ambavane, A.
| +6
Wird geladen...
5
Clinical and economic outcomes of treatment sequences for intermediate- to poor-risk advanced renal cell carcinoma
enthalten in:
Immunotherapy
| 2020
von
Ambavane, A.
|
Yang, S.
|
Atkins, M.
| +5
Wird geladen...
6
Value assessment of immuno-oncology in the treatment of rare tumors in the era of accelerated conditional approvals
enthalten in:
Future oncology (London, England)
| 2019
von
Lanitis, T.
|
Ambavane, A.
|
Zheng, Y.
| +2
Wird geladen...
7
Survival Analysis in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab
enthalten in:
Advances in therapy
| 2019
von
Lanitis, T.
|
Proskorovsky, I.
|
Ambavane, A.
| +4
Wird geladen...
8
Survival Analysis in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab
enthalten in:
Advances in therapy
| 2019
von
Lanitis, T.
|
Proskorovsky, I.
|
Ambavane, A.
| +4
Wird geladen...
9
Survival Analysis in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab
enthalten in:
Advances in therapy
| 2019
von
Lanitis, T.
|
Proskorovsky, I.
|
Ambavane, A.
| +4
Wird geladen...
10
Survival Analysis in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab
enthalten in:
Advances in therapy
| 2019
von
Lanitis, T.
|
Proskorovsky, I.
|
Ambavane, A.
| +4
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
21
Aufsätze
19
E-Artikel
19
E-Ressourcen
2
Gedruckte Aufsätze
Zeitschriftentitel
4
Advances in therapy
4
PloS one
3
Immunotherapy
2
Journal of medical economics
1
ClinicoEconomics and outcomes research : CEOR
1
Expert review of hematology
1
Future oncology (London, England)
1
Journal of clinical oncology : official journal...
1
PLOS ONE
1
Pancreatology : official journal of the Interna...
1
The Journal of neuroscience : the official jour...
1
The journal of neuroscience
Alle anzeigen ...
weniger ...
Thema
15
Journal Article
7
Research Support, Non-U.S. Gov't
4
Avelumab
4
Extrapolation
4
Immuno-oncology
4
Landmark analyses
4
Merkel cell carcinoma
4
Overall survival
4
Post-progression survival
4
Standard parametric analysis
3
31YO63LBSN
3
Antibodies, Monoclonal
3
Antineoplastic Agents
3
BRAF protein, human
3
EC 2.7.11.1
3
Nivolumab
3
Proto-Oncogene Proteins B-raf
2
Antibodies, Monoclonal, Humanized
2
Antineoplastic Agents, Immunological
2
CTLA-4 Antigen
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
5
2020-
16
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
20
Englisch
Haven't found what you're looking for?
Wird geladen...